CoChat

Preclinical Science Regarding Cannabinoids as Analgesics: An Overview

Open access
Lynch, ME · 2005 · Pain Research and Management

The DOI matches its Crossref record; 74 of the 76 references it cites were found in a registry or an index.

Abstract

Modern pharmacology of cannabinoids began in 1964 with the isolation and partial synthesis of delta‐9‐tetrahydrocannabinol, the main psychoactive agent in herbal cannabis. Since then, potent antinociceptive and antihyperalgesic effects of cannabinoid agonists in animal models of acute and chronic pain; the presence of cannabinoid receptors in pain‐processing areas of the brain, spinal cord and periphery; and evidence supporting endogenous modulation of pain systems by cannabinoids has provided support that cannabinoids exhibit significant potential as analgesics. The present article presents an overview of the preclinical science.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2005/169093

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 ) Number of PUBMED citations per five-year period regarding 'cannabinoid' and 'cannabis' research
Figure 1 ) Number of PUBMED citations per five-year period regarding 'cannabinoid' and 'cannabis' researchCC-BY · From the PDF
Figure 2 ) Location of cannabinoid receptors (CB 1 ) in the areas of the nervous system that are important for pain transmission and modulation. PAG Periaqueductal gray; RVM Rostral ventrolateral medulla
Figure 2 ) Location of cannabinoid receptors (CB 1 ) in the areas of the nervous system that are important for pain transmission and modulation. PAG Periaqueductal gray; RVM Rostral ventrolateral medullaCC-BY · From the PDF
Figure 3 ) Biosynthesis of endocannabinoids in the context of the arachidonic acid pathway following tissue damage. 2-AG 2-arachidonylglycerol; AEA N-arachidonoyl-ethanolamine; NADA N-arachidonoyl dopamine
Figure 3 ) Biosynthesis of endocannabinoids in the context of the arachidonic acid pathway following tissue damage. 2-AG 2-arachidonylglycerol; AEA N-arachidonoyl-ethanolamine; NADA N-arachidonoyl dopamineCC-BY · From the PDF
Figure 4 ) Signal transduction mechanisms at the cannabinoid receptor found primarily in the nervous system (CB 1 ). Activation of the receptor stimulates coupling to the G protein with activation of mitogen-activated protein (MAP) kinase and inhibition of adenylyl cyclase with decreased production of cyclic (c)AMP. The G protein also directly couples the CB 1 receptor negatively to N- and Q/P-type voltage-dependent calcium (Ca 2+ ) channels and positively to A-type and inwardly rectifying potassium channels (K + A and K + ir , respectively). Thus, there is enhanced outward K + current resulting in decreased cell firing, and closing of Ca 2+ channels resulting in decreased release of neurotransmitters, resulting in an overall effect of cellular inhibition. PKA Protein kinase A. Adapted from reference 80
Figure 4 ) Signal transduction mechanisms at the cannabinoid receptor found primarily in the nervous system (CB 1 ). Activation of the receptor stimulates coupling to the G protein with activation of mitogen-activated protein (MAP) kinase and inhibition of adenylyl cyclase with decreased production of cyclic (c)AMP. The G protein also directly couples the CB 1 receptor negatively to N- and Q/P-type voltage-dependent calcium (Ca 2+ ) channels and positively to A-type and inwardly rectifying potassium channels (K + A and K + ir , respectively). Thus, there is enhanced outward K + current resulting in decreased cell firing, and closing of Ca 2+ channels resulting in decreased release of neurotransmitters, resulting in an overall effect of cellular inhibition. PKA Protein kinase A. Adapted from reference 80CC-BY · From the PDF
Figure 5 ) Cannabinoid influences on peripheral nerve activity with tissue injury and inflammation. 5-HT 5-hydroxytryptamine; CB 1 Cannabinoid receptors found primarily in nervous system; CB 2 Cannabinoid receptors found primarily in peripheral tissues/immune system; CGRP Calcitonin gene-related peptide; NGF Nerve growth factor; NO Nitric oxide; trk A High affinity NGF receptor. Figure adapted from reference 71
Figure 5 ) Cannabinoid influences on peripheral nerve activity with tissue injury and inflammation. 5-HT 5-hydroxytryptamine; CB 1 Cannabinoid receptors found primarily in nervous system; CB 2 Cannabinoid receptors found primarily in peripheral tissues/immune system; CGRP Calcitonin gene-related peptide; NGF Nerve growth factor; NO Nitric oxide; trk A High affinity NGF receptor. Figure adapted from reference 71CC-BY · From the PDF
Image 6
CC-BY · From the PDF
Image 7
CC-BY · From the PDF
Image 8
CC-BY · From the PDF
Image 9
CC-BY · From the PDF
Image 10
CC-BY · From the PDF
Image 11
CC-BY · From the PDF
Image 12
CC-BY · From the PDF
Image 13
CC-BY · From the PDF
Image 14
CC-BY · From the PDF
Image 15
CC-BY · From the PDF
Image 16
CC-BY · From the PDF
Image 17
CC-BY · From the PDF
Image 18
CC-BY · From the PDF
Image 19
CC-BY · From the PDF
Image 20
CC-BY · From the PDF
Image 21
CC-BY · From the PDF
Image 22
CC-BY · From the PDF
Image 23
CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 5

  1. [14]14. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical localization of cannabinoid CB1 receptors in rat central nervous system. Neuroscience 1998;83:393-411.
  2. [15]15. Herkenham M. Localization of cannabinoid receptors in brain and periphery. In: Pertwee RG, ed. Cannabinoid Receptors. New York: Academic Press 1995:145-66.
  3. [24]24. Gong JP, Onaivi E, Uhl G. Cannabinoid CB2 receptors: Immunhistochemical localization in rat brain. ICRS abstracts. 15th Annual Symposium on the Cannabinoids, Clearwater, Florida, June 24-27, 2005.
  4. [37]37. Martin WJ, Lai NK, Patrick SL, Tsou K, Walker JM. Antinociceptive actions of WIN 55,212-2 following intraventricular administration in rats. Brain Res 1993;629:300-4.
  5. [60]60. Tsou K, Lowitz KA, Hohmann AG, et al. Suppression of noxious stimulus-evoked expression of fos-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience 1995;70:791-8.

Cited by

See all 20

Metadata

Authors
Lynch, M.
Affiliations
Dalhousie University (CA)
Corresponding author
Lynch, ME
Venue
Pain Research and Management
Publisher
Wiley
Published
2005-01
Volume
10
Issue
A
Pages
7A-14A
ISSN
  • 1203-6765 (ISSN-L)
  • 1918-1523
OpenAlex
W2346786802
Cited by
20
References
76
Citations by year
2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 1 · 2012: 1
FWCI
0.35
Type
journal article
Language
en
Open access
Locations
  • Pain Research and Management (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
cannabinoids, analgesics, delta-9-tetrahydrocannabinol, cannabinoid receptors, antinociception, antihyperalgesia, chronic pain, acute pain, endocannabinoid system, pain processing, animal models of pain
MeSH terms
Analgesics, Animals, Brain, Cannabinoids, Pain, Receptors, Cannabinoid, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.